Our data from the functional study confirmed that HCLS1, EVI2B, or CD48 suppresses CRC progression by inhibiting the proliferation, migration, and invasion capacity of CRC cells as well as tumor growth in vivo. Here, HCLS1 is linked to colorectal carcinoma.